Adaptogens & the Mushroom Kingdom — why mushrooms matter for menopausal skin

CHAPTER FOUR  ·  THE RESILIENCE GUIDE

Adaptogens & the Mushroom Kingdom

The fungal signalling molecules that talk to skin cells — and why dose, source, and vehicle decide if any of it reaches you.

By Barbi  ·  10 min read  ·  Founder, PHILOGENI

·  ·  ·

Why does my skin react to things it used to tolerate?

Adaptogen is a word the wellness industry borrowed from Soviet pharmacology in the 1980s and has been misusing ever since. Used precisely, it has a definition. Used loosely, it has very little.

The precise definition came from a Soviet pharmacologist named Nikolai Lazarev in 1947, who was studying substances that helped soldiers, athletes, and factory workers withstand sustained physiological stress. Lazarev's three criteria for an adaptogenic substance were specific and restrictive: it had to be non-toxic at normal doses, it had to produce a normalising effect rather than a stimulating or sedating one, and it had to exert a broad protective action across multiple physiological systems. 1 His successor Israel Brekhman expanded the work through the 1960s and 1970s, 2 and the term entered Western herbal medicine in the late 1980s, by which point it had begun to lose its precision.

The reason this chapter starts with definitions is that adaptogen is not a single class of ingredients, and not all of the substances marketed as adaptogens meet Lazarev's criteria. But the substances that do — and that are also relevant to skin — form a tight, well-characterised category. The largest and most studied is the medicinal mushrooms.

This is where the skincare conversation has been thinnest. Beta-glucans, polysaccharide signalling, the specific bioactives that distinguish one mushroom from another, the receptor-level mechanism that explains why fungal molecules talk to skin cells at all — most of this is missing from the consumer-facing literature. This chapter puts it on the page.

What adaptogens actually are

Adaptogenic substances, as Lazarev defined them, do not stimulate any single system. They modulate. They support the body's existing stress-response machinery — the hypothalamic-pituitary-adrenal axis, the sympathetic nervous system, the cellular mechanisms of oxidative defense and repair — without overriding the body's own regulation. A stimulant pushes a system in one direction; a sedative pushes it in the other; an adaptogen helps the system return to its set point regardless of which direction it has drifted.

This matters topically for one specific reason: the skin has its own stress-response machinery. Keratinocytes and Langerhans cells in the epidermis monitor what is happening at the surface and adjust the inflammatory response accordingly. In healthy young skin, this system is exquisitely regulated. In the hormonal transition, the regulation slips — the inflammatory threshold drops, the recovery time lengthens, and the same provocations that produced no response at thirty produce visible irritation at fifty-five.

The substances that support the body's stress-response systems systemically — adaptogens — turn out to support the same kinds of systems when applied to the skin. The mechanism is partly direct (binding to specific receptors on skin cells) and partly indirect (modulating the local inflammatory environment so the skin's own regulation can recover). Both are clinically relevant. Neither is well-known outside dermatological research.

Of the substances that meet Lazarev's criteria and have published evidence for topical activity, by far the most studied category is medicinal mushrooms. The reason is structural. Mushroom cell walls contain a class of molecules — beta-glucan polysaccharides — that bind directly to receptors on human immune cells, including the keratinocytes and Langerhans cells of the skin. Plant adaptogens (ashwagandha, rhodiola, eleuthero) have their place, but their skin-active compounds are less concentrated and less well-characterised. The mushrooms are the substantial category.

Beta-glucans: the universal mushroom active

Beta-glucans are branched polysaccharides — long chains of glucose units linked by specific chemical bonds. Three things determine whether a given beta-glucan has biological activity: the chemical bond pattern (1,3 versus 1,6 branching), the molecular weight, and the source organism.

Fungal beta-glucans — the kind found in mushroom cell walls — have a 1,3-1,6 branching pattern that is exceptionally well-suited to mammalian immune recognition. They bind to a receptor called Dectin-1, which is expressed on the surface of macrophages, neutrophils, dendritic cells, and the Langerhans cells that police the upper layers of the skin. 3 When a beta-glucan engages Dectin-1, the cell initiates a signalling cascade that modulates the local inflammatory response — typically dampening overactive inflammation while preserving the protective response to genuine threats.

The mechanism is not theoretical. Topically applied beta-glucans have been shown in human skin studies to reduce transepidermal water loss, accelerate barrier recovery after disruption, and reduce visible erythema in sensitive skin. 4 The molecule does not work by sitting on the surface. It works by signalling.

Three implications follow, and they are the implications that distinguish a well-formulated mushroom skincare product from a decorative one.

First, the source matters. Oat beta-glucan (1,3-1,4 branching) binds Dectin-1 less efficiently than mushroom beta-glucan (1,3-1,6 branching). They are not interchangeable, regardless of how the marketing copy reads.

Second, the dose matters. Below a threshold concentration, the beta-glucan dose is insufficient to engage enough receptors to produce a measurable effect. Studies suggesting visible barrier and inflammatory benefit typically use beta-glucan-rich extracts at one to five percent of the formulation. Brands listing mushroom extracts in the ingredient list at a fraction of a percent are not delivering the molecule at a functional dose.

Third, the vehicle matters. Beta-glucans are water-soluble at low molecular weight but require careful formulation to remain bioavailable in oil-phase products. The carrier system either delivers the molecule to the live epidermis or strands it at the surface.

These three implications — source, dose, vehicle — explain why two products that both claim mushroom adaptogens can perform completely differently. The ingredient list tells the reader almost nothing. The chemistry behind the list tells her everything.

The four anchor mushrooms

Beta-glucans are the universal mushroom active, but each medicinal mushroom species contributes additional bioactives on top of its baseline beta-glucan content. The four mushrooms anchoring this discussion were selected because their bioactive profiles are distinct, complementary, and well-documented.

Reishi (Ganoderma lucidum)

The most studied mushroom in Traditional Chinese Medicine, where it has been used for over two thousand years and is sometimes called the mushroom of immortality. Beyond its beta-glucan content, Reishi contains a family of compounds called triterpenes — most notably the ganoderic acids — that have demonstrated anti-inflammatory and immunomodulatory activity in both cellular and animal models. 5 In skin specifically, Reishi extracts have been shown to support barrier recovery and to reduce markers of oxidative stress.

In a formulation, Reishi is the calming layer. It is the mushroom one reaches for when the inflammatory baseline is elevated — which is the condition of most hormonally transitioning skin.

Chaga (Inonotus obliquus)

The mushroom that grows as a black, charred-looking conk on birch trees in northern climates. Chaga's defining characteristic is its melanin content — among the highest of any natural source — which contributes to one of the densest antioxidant profiles ever measured in a botanical extract. Chaga extracts show high superoxide dismutase activity and protect cells from oxidative stress in dermatological studies. 6

In a formulation, Chaga is the antioxidant layer. It complements the lipid-phase antioxidant system (tocopherol, CoQ10) by working in the aqueous environments and at the protein structures that lipid-soluble antioxidants do not reach.

Maitake (Grifola frondosa)

Native to East Asia and parts of eastern North America. Maitake is best known as the source of a specific beta-glucan isolate called D-fraction, which has been the subject of extensive immunological research. 7 D-fraction binds Dectin-1 with particular efficiency and is one of the more potent beta-glucan signal molecules characterised to date.

In a formulation, Maitake is the structural beta-glucan workhorse. Its specific molecular signature deepens the immunomodulatory activity of the complex beyond what any single beta-glucan source could deliver.

Cordyceps (Cordyceps sinensis)

The fruiting body of a fungus that grows on insect larvae in the Himalayan plateau, traditionally used in Tibetan and Chinese medicine for stamina and recovery. Cordyceps contains adenosine and cordycepin — compounds that, applied topically, have been associated with support of cellular energy production and the appearance of skin vitality. 8 The bioactivity profile complements CoQ10's mitochondrial action.

In a formulation, Cordyceps is the energy and vitality layer. It supports the look of resilient, well-rested skin — the visible counterpart to mitochondrial repair.

Why a complex, not a single mushroom

The choice between a single mushroom and a complex is not a matter of bigger-is-better. It is a matter of mechanism.

Each of the anchor mushrooms contributes a distinct bioactive profile on top of its baseline beta-glucan content. Reishi's triterpenes operate through different cellular pathways than Chaga's melanins. Maitake's D-fraction engages Dectin-1 with different kinetics than the beta-glucans in Cordyceps. The complex is not redundant. It is composed.

Dose is similarly considered. A functional mushroom complex sits at around five percent of the formulation — above the threshold at which the polysaccharides have been shown to reach functional concentration at the live epidermis, and within the range used in the published studies that demonstrate barrier and inflammatory benefit. Most adaptogen skincare on the market uses these ingredients at trace amounts, below the threshold at which any of the documented mechanisms can engage. The ingredient list claim is the same. The molecular outcome is not.

This is the defensible scientific territory. Very little of the menopausal skincare market addresses adaptogens at this depth or this dose. The reason most of the category does not is that mushroom extracts at five percent are not cheap, and the formulation expertise required to keep them bioavailable in an oil-phase delivery system is not common. The reader who finishes this chapter understands the difference, and will recognise the gap immediately the next time she reads an ingredient list.

The skin has its own stress-response systems. The molecules that support them are largely fungal — and almost nobody is dosing them functionally.

Sources cited in this chapter

1. Lazarev NV. General and specific action of pharmacological substances. Pharmacology and Toxicology. 1958;21(3):81-86.

2. Brekhman II, Dardymov IV. New substances of plant origin which increase nonspecific resistance. Annual Review of Pharmacology. 1969;9:419-430.

3. Brown GD, Gordon S. Immune recognition of fungal beta-glucans. Cellular Microbiology. 2005;7(4):471-479.

4. Wei D, Williams D, Browder W. Activation of AP-1 and SP1 in human dermal fibroblasts by topical beta-glucan. International Journal of Cosmetic Science. 2002;24(1):17-25.

5. Wachtel-Galor S, Yuen J, Buswell JA, Benzie IFF. Ganoderma lucidum (Lingzhi or Reishi): A Medicinal Mushroom. In: Herbal Medicine: Biomolecular and Clinical Aspects. 2nd edition. Boca Raton (FL): CRC Press; 2011.

6. Géry A, Dubreule C, André V, et al. Chaga (Inonotus obliquus), a Future Potential Medicinal Fungus in Oncology? Integrative Cancer Therapies. 2018;17(3):832-843.

7. Mayell M. Maitake extracts and their therapeutic potential — a review. Alternative Medicine Review. 2001;6(1):48-60.

8. Holliday JC, Cleaver MP. Medicinal Value of the Caterpillar Fungi Species of the Genus Cordyceps. International Journal of Medicinal Mushrooms. 2008;10(3):219-234.

·  ·  ·

© 2026 PHILOGENI Skincare Inc.  ·  Victoria, BC  ·  philogeni.com